TY - JOUR
T1 - Mechanism-Based Inhibitors of the Human Sirtuin 5 Deacylase
T2 - Structure–Activity Relationship, Biostructural, and Kinetic Insight
AU - Rajabi, Nima
AU - Auth, Marina
AU - Troelsen, Kathrin R.
AU - Pannek, Martin
AU - Bhatt, Dhaval P.
AU - Fontenas, Martin
AU - Hirschey, Matthew D.
AU - Steegborn, Clemens
AU - Madsen, Andreas S.
AU - Olsen, Christian A.
N1 - Publisher Copyright:
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
PY - 2017/11/20
Y1 - 2017/11/20
N2 - The sirtuin enzymes are important regulatory deacylases in a variety of biochemical contexts and may therefore be potential therapeutic targets through either activation or inhibition by small molecules. Here, we describe the discovery of the most potent inhibitor of sirtuin 5 (SIRT5) reported to date. We provide rationalization of the mode of binding by solving co-crystal structures of selected inhibitors in complex with both human and zebrafish SIRT5, which provide insight for future optimization of inhibitors with more “drug-like” properties. Importantly, enzyme kinetic evaluation revealed a slow, tight-binding mechanism of inhibition, which is unprecedented for SIRT5. This is important information when applying inhibitors to probe mechanisms in biology.
AB - The sirtuin enzymes are important regulatory deacylases in a variety of biochemical contexts and may therefore be potential therapeutic targets through either activation or inhibition by small molecules. Here, we describe the discovery of the most potent inhibitor of sirtuin 5 (SIRT5) reported to date. We provide rationalization of the mode of binding by solving co-crystal structures of selected inhibitors in complex with both human and zebrafish SIRT5, which provide insight for future optimization of inhibitors with more “drug-like” properties. Importantly, enzyme kinetic evaluation revealed a slow, tight-binding mechanism of inhibition, which is unprecedented for SIRT5. This is important information when applying inhibitors to probe mechanisms in biology.
KW - deacylases
KW - drug discovery
KW - enzyme inhibitors
KW - posttranslational modifications
KW - sirtuins
UR - http://www.scopus.com/inward/record.url?scp=85032818814&partnerID=8YFLogxK
U2 - 10.1002/anie.201709050
DO - 10.1002/anie.201709050
M3 - Article
C2 - 29044784
AN - SCOPUS:85032818814
SN - 1433-7851
VL - 56
SP - 14836
EP - 14841
JO - Angewandte Chemie - International Edition
JF - Angewandte Chemie - International Edition
IS - 47
ER -